IP Verse

Use Of Cannabinoids In The Treatment Of Seizures Associated With Lennox-Gastaut Syndrome - EP3710058

The patent EP3710058 was granted to GW Research on Oct 9, 2024. The application was originally filed on Nov 15, 2018 under application number EP18808075A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP3710058

GW RESEARCH
Application Number
EP18808075A
Filing Date
Nov 15, 2018
Status
Granted And Under Opposition
Sep 6, 2024
Grant Date
Oct 9, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

KRAUS & LEDERER PARTGMBBJul 8, 2025ADMISSIBLE

Patent Citations (3) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
INTERNATIONAL-SEARCH-REPORTGB2531282
INTERNATIONAL-SEARCH-REPORTUS2017224634
OPPOSITIONWO2016059403

Non-Patent Literature (NPL) Citations (14) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
EXAMINATION- OSTENDORF ADAM ET AL, "Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions", NEUROPSYCHIATRIC DISEASE AND TREATMENT, Volume 13, doi:10.2147/NDT.S115996, (20170401), pages 1131 - 1140, URL: https://www.dovepress.com/getfile.php?fileID=36134, (20220706), XP055939166
INTERNATIONAL-SEARCH-REPORT- Alicia Ciccone, "Drop Seizure Frequency in Lennox-Gastaut Decreased With Cannabidiol", Neurology Advisor, (20170426), pages 1 - 3, URL: https://www.neurologyadvisor.com/aan-2017-coverage/aan-2017-cannabidiol-reduces-drop-seizures-in-lennox-gastaut-syndrome/article/652931/, (20190117), XP055544182 [X] 1,3,5-7,9 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- O Devinsky ET AL, "Efficacy and safety of Epidiolex (cannabidiol) in children and young adults with treatment-resistant epilepsy: Initial data from expanded access program", (20150101), URL: https://www.aesnet.org/meetings_events/annual_meeting_abstracts/view/2414222, (20190207), XP055553292 [X] 1,3,5-9 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- WIRRELL E ET AL, "Cannabidiol (CBD) significantly reduces drop and total seizure frequency in lennox gastaut syndrome (LGS): Results of a dose ranging, multicenter, randomized, double blind, placebo controlled trial (GWPCARE3)", (20171001), URL: http://ir.gwpharm.com/static-files/d489e19a-7769-4dcb-97fc-60ed923b0a2d, XP002788724 [X] 1,3,5-7,9 * the whole document *-
INTERNATIONAL-SEARCH-REPORT- DEVINSKY ORRIN ET AL, "Cannabidiol in patients with treatment-resistant epilepsy: an open-label interventional trial", LANCET NEUROLOGY, LANCET PUBLISHING GROUP, LONDON, GB, (20151224), vol. 15, no. 3, doi:10.1016/S1474-4422(15)00379-8, ISSN 1474-4422, pages 270 - 278, XP029415431 [X] 1,3,5-9 * the whole document *
OPPOSITION- Alicia Ciccone, "Drop Seizure Frequency in Lennox-Gastaut Decreased With Cannabidiol", Neurology Advisor, (20170426), pages 1 - 3, Neurology Advisor, URL: https://www.neurologyadvisor.com/aan-2017-coverage/aan-2017-cannabidiol-reduces-drop-seizures-in-lennox-gastaut-syndrome/article/652931/, (20190117), XP055544182-
OPPOSITION- Patel1 Anup D, Et Al. , "Cannabidiol (CBD) Significantly Reduces Drop Seizure Frequency in Lennox-Gastaut Syndrome (LGS): Results of a Multi-Center, Randomized, Double-Blind, Placebo-Controlled Trial (GWPCARE3)", 69th Annual Meeting of the American Academy of Neurology, Poster Presentation, (20170422), XP093297282-
OPPOSITION- Patel Anup, Et Al., "Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a dose-ranging, multi-center, randomized, double-blind, placebo-controlled trial (GWPCARE3)", Neurology, (20170822), vol. 89, page e100, XP093297288-
OPPOSITION- Thiele Elizabeth A., Et Al., "Cannabidiol (CBD) Significantly Reduces Drop Seizure Frequency in Lennox-Gastaut Syndrome (LGS): Resultsofa Multi-center, Randomized, Double-blind, Placebo-controlled Trial (GWPCARE4)", American Epilepsy Society Annual Meeting, Poster Presentation, (20161203), XP093297280-
OPPOSITION- Thiele Elizabeth A., Mazurkiewicz-Beldzinska Maria, Benbadis Selim R., Marsh Eric D., "Cannabidiol (CBD) significantly reduces drop seizure frequency in Lennox-Gastaut syndrome (LGS): results of a multi-center, randomized, double-blind, placebo controlled trial (GWPCARE4) ", (20161121), XP093297284-
OPPOSITION- French Jacqueline A.; Schachter Steven C.; Sirven Joseph; Porter Roger, "The Epilepsy Foundation's 4th Biennial Epilepsy Pipeline Update Conference", EPILEPSY AND BEHAVIOR, ACADEMIC PRESS, SAN DIEGO, CA, US, US , (19000101), vol. 46, doi:10.1016/j.yebeh.2015.02.033, ISSN 1525-5050, pages 34 - 50, XP029239178
OPPOSITION- O'Connell Brooke K.; Gloss David; Devinsky Orrin, "Cannabinoids in treatment-resistant epilepsy: A review", EPILEPSY AND BEHAVIOR, ACADEMIC PRESS, SAN DIEGO, CA, US, US , (20170208), vol. 70, doi:10.1016/j.yebeh.2016.11.012, ISSN 1525-5050, pages 341 - 348, XP085033477
OPPOSITION- Ostendorf Adam, Ng Yu-Tze, "Treatment-resistant Lennox-Gastaut syndrome: therapeutic trends, challenges and future directions", Neuropsychiatric Disease and Treatment, Volume 13, doi:10.2147/NDT.S115996, pages 1131 - 1140, XP055939166
OPPOSITION- Cross J. Helen, Auvin Stéphane, Falip Mercè, Striano Pasquale, Arzimanoglou Alexis, "Expert Opinion on the Management of Lennox-Gastaut Syndrome: Treatment Algorithms and Practical Considerations", Frontiers in Neurology, Frontiers Research Foundation, (20170101), vol. 8, doi:10.3389/fneur.2017.00505, ISSN 1664-2295, page 505, XP093297290

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents